Get notified when AIDX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: AIDX 20/20 Biolabs, Inc. 8-K

20/20 Biolabs reports full-year 2025 financial results via press release

Filed April 1, 2026 · Period ending March 31, 2026 · ~1 min read

Key Changes

  • high

    Company issued press release disclosing financial results for year ended December 31, 2025. Actual revenue, earnings, and performance metrics are in the attached exhibit, not the 8-K body itself.

    Item 2.02 verify on EDGAR →
  • medium

    Filing references March 31, 2026 press release but provides no financial details in the main document. Investors must review Exhibit 99.1 for complete results.

    8-K: Earnings verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.

Partner

Trade AIDX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov Press release (Ex 99.1) on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify